Adjuvant chemotherapy using gemcitabine+ CDDPin patients with resected biliary cancer, phase II study
Phase 2
- Conditions
- resected bile duct cancer
- Registration Number
- JPRN-UMIN000010501
- Lead Sponsor
- Dokkyo Medical Uniiversity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
1)Recurrence before registration 2)evidence of ascites and pleural effusion. 3)Evidence of cardiac effusion 4)Patients have pneumonia or pleural fibrosis. 5)Uncontrolled diarrhea 6)No evidence of OMI 3 months before registration. 7) No viral hepatitis 8)Uncontrolled DM 9)No BTF 2 week before registration. 10)There are not complication, such as cardiac, renal failure and/or liver failure, peptic ulcer, bowel pararitic disorder and stable for mental status. 11)no allergy. 12)No evidence of other organ malignancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method disease free survival
- Secondary Outcome Measures
Name Time Method